Rebecca Taub

2017

In 2017, Rebecca Taub earned a total compensation of $1.1M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals, a 34% decrease compared to previous year.

Compensation breakdown

Bonus$247,900
Salary$370,000
Stock Awards$473,337
Other$558
Total$1,091,795

Taub received $473.3K in stock awards, accounting for 43% of the total pay in 2017.

Taub also received $247.9K in bonus, $370K in salary and $558 in other compensation.

Rankings

In 2017, Rebecca Taub's compensation ranked 8,570th out of 14,666 executives tracked by ExecPay. In other words, Taub earned more than 41.6% of executives.

ClassificationRankingPercentile
All
8,570
out of 14,666
42nd
Division
Manufacturing
3,251
out of 5,768
44th
Major group
Chemicals And Allied Products
1,085
out of 2,074
48th
Industry group
Drugs
859
out of 1,730
50th
Industry
Pharmaceutical Preparations
670
out of 1,329
50th
Source: SEC filing on April 27, 2018.

Taub's colleagues

We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2017.

2017

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2017

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

You may also like